Available studies (212 found)
Short citation | Full citation | Bioassay | Epidemiology | Epi. meta-analysis | In vitro | Ecology |
---|---|---|---|---|---|---|
ECHA 2007b, 6386785 | European Chemicals Agency (ECHA). Registration dossier: (S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane; reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane (CASRN: 138495-42-8): Toxicity to reproduction: 001 Key | Experimental result. HERO | |||||
ECHA 2008, 6385529 | European Chemicals Agency (ECHA). Registration dossier: 1,1,2,2,3,3,4,4-octafluoro-1,4-diiodobutane (CASRN: 375-50-8): Repeated dose toxicity: inhalation: 001 Key | Experimental result. HERO | |||||
ECHA 2008, 6385530 | ECHA. Registration dossier: 1,1,2,2,3,3,4,4-octafluoro-1,4-diiodobutane (CASRN: 375-50-8): Repeated dose toxicity: inhalation: 002 Supporting | Experimental result. HERO | |||||
ECHA 2008, 6385547 | ECHA. Registration dossier: 1,6-diiodoperfluorohexane (CASRN: 375-80-4): Repeated dose toxicity: inhalation: 002 Supporting | Experimental result. HERO | |||||
ECHA 2008, 6385679 | ECHA. Registration dossier: 2,2,3,3,4,4,5,5-octafluoropentyl methacrylate (CASRN: 355-93-1): Acute Toxicity: oral: Key | Experimental result. HERO | |||||
ECHA 2009, 6385538 | ECHA. Registration dossier: 1,1,2,2,3,3,4,4-octafluoro-1,4-diiodobutane (CASRN: 375-50-8): Acute Toxicity: inhalation: 002 Other | Experimental result. HERO | |||||
ECHA 2009, 6385546 | European Chemicals Agency (ECHA). Registration dossier: 1,6-diiodoperfluorohexane (CASRN: 375-80-4): Repeated dose toxicity: inhalation: 001 Key | Experimental result. HERO | |||||
ECHA 2009, 6385659 | ECHA. Registration dossier: 2,2,3,3,4,4,5,5-octafluoropentyl methacrylate (CASRN: 355-93-1): Repeated dose toxicity: oral: Supporting | Experimental result. HERO | |||||
ECHA 2009, 6385660 | ECHA. Registration dossier: 2,2,3,3,4,4,5,5-octafluoropentyl methacrylate (CASRN: 355-93-1): Repeated dose toxicity: inhalation: Supporting | Experimental result. HERO | |||||
ECHA 2010, 6385401 | European Chemicals Agency (ECHA). Registration dossier: 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl )-3-pentanone (CASRN: 756-13-8): Repeated dose toxicity: inhalation: 001 Key | Experimental result. HERO | |||||
ECHA 2010a, 6385620 | European Chemicals Agency (ECHA). Registration dossier: 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane (CASRN: 297730-93-9): Toxicity to reproduction: Key | Experimental result. HERO | |||||
ECHA 2010c, 6386941 | European Chemicals Agency (ECHA). Registration dossier 2: 1,1,1,3,3,3-hexafluoropropan-2-ol (CASRN: 920-66-1): Toxicity to reproduction: Key | Experimental result. HERO | |||||
ECHA 2012a, 6385408 | European Chemicals Agency (ECHA). Registration dossier: 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl )-3-pentanone (CASRN: 756-13-8): Toxicity to reproduction: 001 Key | Other result type. HERO | |||||
ECHA 2012b, 6385409 | European Chemicals Agency (ECHA). Registration dossier: 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl )-3-pentanone (CASRN: 756-13-8): Developmental toxicity/teratogenicity: Key | Experimental result. HERO | |||||
ECHA 2014, 6385528 | European Chemicals Agency (ECHA). Registration dossier: 1,1,2,2,3,3,4,4-octafluoro-1,4-diiodobutane (CASRN: 375-50-8): Repeated dose toxicity: oral: Supporting | Experimental result. HERO | |||||
ECHA 2014, 6385531 | ECHA. Registration dossier: 1,1,2,2,3,3,4,4-octafluoro-1,4-diiodobutane (CASRN: 375-50-8): Repeated dose toxicity: inhalation: 003 Supporting | Experimental result. HERO | |||||
ECHA 2014, 6385585 | ECHA. Registration dossier: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctane-1-thiol (CASRN: 34451-26-8): Acute Toxicity: oral: 001 Key | Experimental result. HERO | |||||
ECHA 2014, 6385586 | ECHA. Registration dossier: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctane-1-thiol (CASRN: 34451-26-8): Acute Toxicity: oral: 002 Key | Experimental result. HERO | |||||
ECHA 2015, 6385553 | ECHA. Registration dossier: Trimethoxy(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)silane (CASRN: 85857-16-5): Acute Toxicity: oral: Key | Experimental result. HERO | |||||
ECHA 2016a, 6385683 | European Chemicals Agency (ECHA). Registration dossier: (E)-1,1,1,2,3,4,5,5,5-Nonafluoro-4-(trifluoromethyl)pent-2-ene (CASRN: 3709-71-5): Repeated dose toxicity: inhalation: 001 Key | Experimental result. HERO | |||||
ECHA 2016b, 6385688 | European Chemicals Agency (ECHA). Registration dossier: (E)-1,1,1,2,3,4,5,5,5-Nonafluoro-4-(trifluoromethyl)pent-2-ene (CASRN: 3709-71-5): Toxicity to reproduction: 001 Key | Experimental result. HERO | |||||
ECHA 2017, 6385483 | ECHA. Registration dossier: 1,1,1,3,3,3-hexafluoro-2-methoxypropane (CASRN: 13171-18-1): Acute Toxicity: oral: Key | Experimental result. HERO | |||||
ECHA 2017a, 6385515 | European Chemicals Agency (ECHA). Registration dossier: Trideca-1,1,1,2,2,3,3,4,4,5,5,6,6-fluorohexane (CASRN: 355-37-3): Repeated dose toxicity: oral: 001 Key | Experimental result. HERO | |||||
ECHA 2017b, 6385520 | European Chemicals Agency (ECHA). Registration dossier: Trideca-1,1,1,2,2,3,3,4,4,5,5,6,6-fluorohexane (CASRN: 355-37-3): Toxicity to reproduction: Key | Experimental result. HERO | |||||
ECHA 2017c, 6385521 | European Chemicals Agency (ECHA). Registration dossier: Trideca-1,1,1,2,2,3,3,4,4,5,5,6,6-fluorohexane (CASRN: 355-37-3): Developmental toxicity/teratogenicity: Key | Experimental result. HERO |
Showing studies 76-100 of 212